Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2009 | 1 |
2010 | 1 |
2011 | 1 |
2014 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Antitumor efficacy of the anti-interleukin-6 (IL-6) antibody siltuximab in mouse xenograft models of lung cancer.
J Thorac Oncol. 2014 Jul;9(7):974-982. doi: 10.1097/JTO.0000000000000193.
J Thorac Oncol. 2014.
PMID: 24922005
Free PMC article.
Mirk/Dyrk1B, a novel therapeutic target, mediates cell survival in non-small cell lung cancer cells.
Gao J, Zheng Z, Rawal B, Schell MJ, Bepler G, Haura EB.
Gao J, et al.
Cancer Biol Ther. 2009 Sep;8(17):1671-9. doi: 10.4161/cbt.8.17.9322. Epub 2009 Sep 20.
Cancer Biol Ther. 2009.
PMID: 19633423
Free PMC article.
Item in Clipboard
JAK1 activates STAT3 activity in non-small-cell lung cancer cells and IL-6 neutralizing antibodies can suppress JAK1-STAT3 signaling.
Song L, Rawal B, Nemeth JA, Haura EB.
Song L, et al.
Mol Cancer Ther. 2011 Mar;10(3):481-94. doi: 10.1158/1535-7163.MCT-10-0502. Epub 2011 Jan 7.
Mol Cancer Ther. 2011.
PMID: 21216930
Free PMC article.
Item in Clipboard
A pilot study of preoperative gefitinib for early-stage lung cancer to assess intratumor drug concentration and pathways mediating primary resistance.
Haura EB, Sommers E, Song L, Chiappori A, Becker A.
Haura EB, et al.
J Thorac Oncol. 2010 Nov;5(11):1806-14. doi: 10.1097/JTO.0b013e3181f38f70.
J Thorac Oncol. 2010.
PMID: 20881637
Free PMC article.
Item in Clipboard
Cite
Cite